Lacosamide-d3 |
|
| Synonyms: (2R)-2-(Acetylamino)-3-(methoxy-d3)-N-(phenylmethyl)propanamide; (2R)-2-(Acetamido-d3)-N-benzyl-3-methoxypropanamide; ADD 243037-d3; Erlosamide-d3; Harkoseride-d3; Lacosamide-d3; SPM 927-d3; Vimpat-d3; | |
| Cat. No.: L00740 | CAS No.: 1217689-95-6/175481-36-4 (unlabelled) |
| MDL.: | Formula: C13H15D3N2O3 |
| F.W.253.31 | Purity: 99% |
| Storage: Refrigerator | |
|   | |
| Catalog Number: | L00740 | CAS No.: | 1217689-95-6/175481-36-4 (unlabelled) | |
| MDL: | Formula: | C13H15D3N2O3 | ||
| F.W.: | 253.31 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | Off-White to Pale Pink | M.P.: | 143-145°C | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Chlorform, Methanol | Stability: | ||
| Storage: | Refrigerator | Category: | Reference Standard | |
| Reference: | Lees, G., et al.: Brain Res., 612, 190 (1993),Kuo, C., et al.: Mol. Pharmacol., 51, 1077 (1997), Barton, M., et al.: Epilepsy Res., 47, 217 (2001), Beyreuther, B., et al.: Eur. J. Pharmacol., 539, 64 (2006),Beyreuther, B., et al.: CNS Drug Rev., 13, 21 (2007), | |||
| Application: | Labelled Lacosamide . Lacosamide is a medication used for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. Lacosamide is a potent anticonvulsant. | |||
| Category: | Amino Acids & Derivatives, Isotope Labelled Compounds, Pharmaceuticals, Intermediates & Fine Chemicals, | |||








